|
Pronunciation |
|
(koks
i dee OH i din skin
test) |
|
|
U.S. Brand
Names |
|
Spherulin® |
|
|
Generic
Available |
|
No |
|
|
Pharmacological Index |
|
Diagnostic Agent |
|
|
Use |
|
Intradermal skin test in diagnosis of coccidioidomycosis; differential
diagnosis of this disease from histoplasmosis, sarcoidosis and other mycotic and
bacterial infections. The skin test may be negative in severe forms of disease
(anergy) or when prolonged periods of time have passed since
infection. |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Stability |
|
Refrigerate |
|
|
Usual Dosage |
|
Children and Adults: Intradermally: 0.1 mL of 1:100 or flexor surface of
forearm
Negative reaction: A negative test means the individual has not been
sensitized to coccidioidin or has lost sensitivity |
|
|
Patient
Information |
|
Test must be read at 24 and 48 hours |
|
|
Nursing
Implications |
|
Patient should be matched for at least 15 minutes after injection for
immediate hypersensitivity response |
|
|
Dosage Forms |
|
Injection: 1:10 (0.5 mL); 1:100 (1
mL) |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|